Researchers have determined why certain stem cells are able to stay stem cells. An enzyme that changes the way DNA is packaged in cells allows specific genes to be turned on and off, thereby preventing a stem cell from becoming another cell type.
Shire plc announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB (ActRIIB) class of molecules being developed by Acceleron Pharma Inc.
Daiichi Sankyo Company, Limited announced that the United States Court of Appeals has affirmed the U.S. District Court decision in patent litigation against Mylan, upholding the validity of the Daiichi Sankyo U.S. patent covering Benicar, Benicar HCT, and AZOR.
Federal health regulators are warning doctors that a class of injectable drugs used in MRI medical imaging scans can cause a rare and sometimes fatal condition in patients with kidney disease.
Doctors and AIDS activists urged African governments to fulfill a decade-old pledge to spend more of their own money on health if they want international help in fighting AIDS.
Affymetrix has launched the GeneAtlas System, which offers a complete personal solution for processing Affymetrix microarrays including stations for fluidics, imaging and hybridization, a computer workstation, and analysis software.
TTP LabTech has validated a new cell colony formation assay on the Acumen eX3 fluorescence microplate cytometer in collaboration with ChemPartner.
Oxford Gene Technology (OGT), provider of clinical genetics and diagnostic solutions to advance molecular medicine, has introduced the CytoSure ISCA UPD 4 x 180k array.
Cetero Research is launching a series of scientific seminars, “An Accelerated Path to Proof-of-Concept in Drug Development,” designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase 1 and 2a clinical trial designs.
Roche NimbleGen announces that Southern California-based genomic services provider Ambry Genetics has officially become a Certified Service Provider for the NimbleGen SeqCap EZ Exome workflow.
Elimination of a molecular gatekeeper leads to the development of arthritis in mice, scientists report. The newly discovered gatekeeper is a protein that determines the fate of damaging cells that mistakenly attack the body's own tissues and lead to autoimmune disorders.
Two opportunistic pathogens that were once thought to be very different have evolved some sexual reproduction and disease-causing habits that are not only similar but also suggest that in the microbial world sex and virulence are closely linked.
The wasting disease associated with some cancers that is typically seen affecting skeletal muscles can also cause significant damage to the heart, new research in mice suggests.
A team of researchers has for the first time identified a gene that is required for memory formation in the common fruit fly. The gene may have similar functions in humans shedding light on neurological disorders such as Alzheimer's disease.
DSM BioSolutions and PolyTherics Limited, an innovator in precision engineering of proteins, announced that they have entered into an agreement for the process development and manufacture of PolyTherics’ lead biobetter product, HiPEG IFN ?-2a.